Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1875 (LINC01875) is a human gene encoding a long non-coding RNA (>200 nucleotides) that does not overlap with protein-coding loci. It belongs to the class of long intergenic non-coding RNAs (lincRNAs), a subset of long non-coding RNAs that are implicated in diverse processes of gene regulation, such as chromatin remodeling, transcriptional and post-transcriptional regulation, and possibly in disease, especially cancer. LINC01875 itself has been identified as one of the lncRNAs differentially expressed in tumor versus normal samples during biomarker discovery for cancers such as lung cancer, but its precise molecular function, protein partners, and disease mechanisms are not well-characterized[1][2][3][5][7]. No evidence establishes it as a direct drug target or details interacting drugs.
Not established for LINC01875; lincRNAs in general may modulate gene expression through binding to regulatory proteins or RNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1875 (LINC01875).